These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7628993)

  • 1. Penetration of pefloxacin and ciprofloxacin into lung tissue.
    Scaglione F; Mezzetti M; Arcidiacono MM; Gattei G; Fraschini F
    J Antimicrob Chemother; 1995 Apr; 35(4):557-9. PubMed ID: 7628993
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves.
    Sharma PK; Ahmad AH; Sharma LD; Varma R
    Vet J; 2003 Jul; 166(1):101-4. PubMed ID: 12788024
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R; Baldwin DR; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
    Vallée E; Azoulay-Dupuis E; Bauchet J; Pocidalo JJ
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
    Baldwin DR; Wise R; Andrews JM; Gill M; Honeybourne D
    Respir Med; 1993 Nov; 87(8):595-601. PubMed ID: 8290743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck.
    Intorre L; Mengozzi G; Bertini S; Bagliacca M; Luchetti E; Soldani G
    Vet Res Commun; 1997 Feb; 21(2):127-36. PubMed ID: 9061885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog.
    Cester CC; Toutain PL
    J Pharm Sci; 1997 Oct; 86(10):1148-55. PubMed ID: 9344173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
    Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring.
    Aramayona JJ; Mora J; Fraile LJ; García MA; Abadía AR; Bregante MA
    Am J Vet Res; 1996 Apr; 57(4):547-53. PubMed ID: 8712523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
    Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D
    J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic drug monitoring of fluoroquinolone].
    Matsumoto F; Takahashi T; Morita M
    Nihon Rinsho; 1990 Feb; 48 Suppl():1217-22. PubMed ID: 2355524
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
    Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
    Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchopulmonary penetration of ciprofloxacin.
    Loos U; Marklein G; Scholl H
    J Chemother; 1989 Jul; 1(4 Suppl):560-1. PubMed ID: 16312532
    [No Abstract]   [Full Text] [Related]  

  • 16. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H; Richter WF; Hendrickx AG
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of ciprofloxacin into human lung tissue after oral and i.v. dosing.
    Caruso E; Castro JM; Chamoles N; Galimberti R; Jorge L; Rohwedder R
    J Chemother; 1989 Jul; 1(4 Suppl):549-51. PubMed ID: 16312527
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in cows following single dose intravenous administration.
    Varma R; Ahmad AH; Sharma LD; Aggarwal P; Ahuja V
    J Vet Pharmacol Ther; 2003 Aug; 26(4):303-5. PubMed ID: 12887614
    [No Abstract]   [Full Text] [Related]  

  • 19. Placental transfer of enrofloxacin and ciprofloxacin in rabbits.
    Aramayona JJ; Garcia MA; Fraile LJ; Abadía AR; Bregante MA
    Am J Vet Res; 1994 Sep; 55(9):1313-8. PubMed ID: 7802401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():194-6. PubMed ID: 8549301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.